Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 16 May 2019 – 20 Aug 2026, limited by ITI Multi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ITI Multi Cap Fund | Nifty 500 |
|---|---|---|
| 16 May 2019 | ₹100.00 | ₹100.00 |
| 23 Dec 2019 | ₹112.43 | ₹107.33 |
| 31 Jul 2020 | ₹95.54 | ₹97.98 |
| 09 Mar 2021 | ₹131.77 | ₹136.82 |
| 16 Oct 2021 | ₹153.19 | ₹171.00 |
| 25 May 2022 | ₹120.97 | ₹147.35 |
| 02 Jan 2023 | ₹141.54 | ₹168.34 |
| 11 Aug 2023 | ₹162.59 | ₹182.83 |
| 19 Mar 2024 | ₹198.07 | ₹212.66 |
| 26 Oct 2024 | ₹231.11 | ₹243.98 |
| 04 Jun 2025 | ₹232.59 | ₹247.33 |
| 11 Jan 2026 | ₹235.39 | ₹254.48 |
| 20 Aug 2026 | ₹264.51 | ₹254.98 |
| Metric | ITI · Regular NAV ₹26.49 Very High risk ★★☆☆☆ | Category median Multi Cap Fund · 33 funds |
|---|---|---|
| +12.59% | +8.06% | |
| +17.75% | +15.20% | |
| +14.15% | +14.26% | |
| — | +14.26% | |
| +14.33% | +14.72% | |
| +16.12% | — | |
| +16.78% | +16.83% | |
| +16.62% | +15.79% | |
| — | +14.87% | |
| Risk | ||
| 16.24% | 14.84% | |
| 0.69 | 0.56 | |
| 0.93 | 0.76 | |
| -38.88% | -20.32% | |
| Nifty 500 | — | |
| +4.41% | +2.81% | |
| 1.08 | 1.01 | |
| 120.2% | 110.1% | |
| 103.8% | 95.9% | |
| 2.32% | 2.21% | |
| ₹1,382Cr | ₹3,513Cr | |
| 0.50% | — | |
| None | — | |
| ₹500 | — | |
| ₹1.00K | — | |
| 531% | 56% | |
| Rajesh Bhatia | — | |
| 16 May 2019 | — | |
| 72 | — | |
| 27.7% | — | |
| 1.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.